Nothing Special   »   [go: up one dir, main page]
create a website
The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation. (2010). Richards-Shubik, Seth ; Markowitz, Sara ; David, Guy.
In: American Economic Journal: Economic Policy.
RePEc:aea:aejpol:v:2:y:2010:i:4:p:1-25.

Full description at Econpapers || Download paper

Cited: 17

Citations received by this document

Cites: 31

References cited by this document

Cocites: 44

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. Opium Price Shocks and Prescription Opioids in the USA*. (2024). Nisticò, Roberto ; Giua, Ludovica ; Deiana, Claudio.
    In: Oxford Bulletin of Economics and Statistics.
    RePEc:bla:obuest:v:86:y:2024:i:3:p:449-484.

    Full description at Econpapers || Download paper

  2. How Do Restrictions on Advertising Affect Consumer Search?. (2022). Tucker, Catherine E ; Chiou, Lesley.
    In: Management Science.
    RePEc:inm:ormnsc:v:68:y:2022:i:2:p:866-882.

    Full description at Econpapers || Download paper

  3. Breaking the Word Bank: Measurement and Effects of Bank Level Uncertainty. (2021). Soto, Paul E.
    In: Journal of Financial Services Research.
    RePEc:kap:jfsres:v:59:y:2021:i:1:d:10.1007_s10693-020-00338-5.

    Full description at Econpapers || Download paper

  4. How Does Regulation Impact Strategic Repositioning by Firms Across Submarkets? Evidence from the Indian Pharmaceutical Industry. (2021). Pennings, Enrico ; Chatterjee, Chirantan ; Anurag, Priyatam ; Bhaskarabhatla, Ajay.
    In: Strategy Science.
    RePEc:inm:orstsc:v:6:y:2021:i:3:p:209-227.

    Full description at Econpapers || Download paper

  5. Opium Price Shocks and Prescription Opioids in the US. (2020). Nistic, R ; Giua, L ; Deiana, C.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:20/23.

    Full description at Econpapers || Download paper

  6. The Economics Behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US. (2019). Nisticò, Roberto ; Giua, Ludovica ; Nistico, Roberto ; Deiana, Claudio.
    In: CSEF Working Papers.
    RePEc:sef:csefwp:525.

    Full description at Econpapers || Download paper

  7. Drug Diffusion Through Peer Networks: The Influence of Industry Payments. (2019). Zeltzer, Dan ; Agha, Leila.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26338.

    Full description at Econpapers || Download paper

  8. The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US. (2019). Nisticò, Roberto ; Nistico, Roberto ; Giua, Ludovica ; Deiana, Claudio.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp12872.

    Full description at Econpapers || Download paper

  9. Do women managers keep firms out of trouble? Evidence from corporate litigation and policies. (2019). Malm, James ; Agrawal, Anup ; Adhikari, Binay K.
    In: Journal of Accounting and Economics.
    RePEc:eee:jaecon:v:67:y:2019:i:1:p:202-225.

    Full description at Econpapers || Download paper

  10. Direct-to-consumer advertising and online search. (2019). Jin, Ginger Zhe ; Chesnes, Matthew .
    In: Information Economics and Policy.
    RePEc:eee:iepoli:v:46:y:2019:i:c:p:1-22.

    Full description at Econpapers || Download paper

  11. Effects of Physician‐directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence. (2017). Dave, Dhaval ; Datta, Anusua .
    In: Health Economics.
    RePEc:wly:hlthec:v:26:y:2017:i:4:p:450-468.

    Full description at Econpapers || Download paper

  12. Direct-to-Consumer Advertising and Online Search. (2016). Chesnes, Matthew ; Jin, Ginger Zhe.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:22582.

    Full description at Econpapers || Download paper

  13. Effects of Physician-Directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence. (2013). Dave, Dhaval ; Datta, Anusua .
    In: NBER Working Papers.
    RePEc:nbr:nberwo:19592.

    Full description at Econpapers || Download paper

  14. Effects of Pharmaceutical Promotion: A Review and Assessment. (2013). Dave, Dhaval.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:18830.

    Full description at Econpapers || Download paper

  15. Eliminating the U.S. drug lag: Implications for drug safety. (2013). Olson, Mary.
    In: Journal of Risk and Uncertainty.
    RePEc:kap:jrisku:v:47:y:2013:i:1:p:1-30.

    Full description at Econpapers || Download paper

  16. The Economics of Personalization in Prevention and Public Health. (2013). Kenkel, Donald ; Kenkel Don S., ; Hua, Wang .
    In: Forum for Health Economics & Policy.
    RePEc:bpj:fhecpo:v:16:y:2013:i:2:p:87-105:n:3.

    Full description at Econpapers || Download paper

  17. Side Effects of Competition: the Role of Advertising and Promotion in Pharmaceutical Markets. (2011). Markowitz, Sara ; David, Guy.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:17162.

    Full description at Econpapers || Download paper

References

References cited by this document

  1. Almasi, Elizabeth A., Randall S. Stafford, Richard L. Kravitz, and Peter R. Mansfield. 2006. “What are the Public Health Effects of Direct-to-Consumer Drug Advertising?” PLoS Medicine, 3(3). Ashraf, Nava, James Berry, and Jesse M. Shapiro. Forthcoming. “Can Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia.” American Economic Review.

  2. Baciu, Alina, Kathleen Stratton, and Sheila P. Burke, ed. 2007. The Future Of Drug Safety: Promoting And Protecting The Health Of The Public. Washington, DC: The National Academies Press.
    Paper not yet in RePEc: Add citation now
  3. Berndt, Ernst R. 2007. “The United States’ Experience with Direct-to-Consumer Advertising of Prescription Drugs: What Have We Learned?” In Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective, ed. Frank A. Sloan and Chee-Ruey Hsieh, 174–95. Cambridge, UK: Cambridge University Press.
    Paper not yet in RePEc: Add citation now
  4. Berndt, Ernst R., Adrian H. B. Gottschalk, Tomas J. Philipson, and Matthew W. Strobeck. 2005. “Industry Funding of the FDA: Effects of PDUFA on Approval Times and Withdrawal Rates.” Nature Reviews Drug Discovery, 4(7): 545–54.
    Paper not yet in RePEc: Add citation now

  5. Bradford, W. David, Andrew N. Kleit, Paul J. Nietert, Terrence Steyer, Thomas McIlwain, and Steven Ornstein. 2006. “How Direct-To-Consumer Television Advertising For Osteoarthritis Drugs Affects Physicians’ Prescribing Behavior.” Health Affairs, 25(5): 1371–77.

  6. Brekke, Kurt R., and Michael Kuhn. 2006. “Direct to Consumer Advertising in Pharmaceutical Markets. ” Journal of Health Economics, 25(1): 102–30.

  7. Brick, Ivan E., and Harsharanjeet S. Jagpal. 1981. “Monopoly Price-Advertising Decision-Making under Uncertainty.” Journal of Industrial Economics, 29(3): 279–85.

  8. Buckley, Joan. 2004. “The Need to Develop Responsible Marketing Practice in the Pharmaceutical Sector.” Problems and Perspectives in Management, 4: 92–103.
    Paper not yet in RePEc: Add citation now
  9. Cameron, A. Colin, and Pravin K. Trivedi. 1998. Regression Analysis of Count Data. Cambridge, UK: Cambridge University Press.
    Paper not yet in RePEc: Add citation now

  10. Cameron, A. Colin, and Pravin K. Trivedi. 2005. Microeconometrics Methods and Applications. New York: Cambridge University Press.

  11. Chao, Blenda A. 2005. “Evaluating the Educational Content of Direct-to-Consumer Fulfillment Materials. ” American Journal of Health-System Pharmacy, 62(6): 620–25.
    Paper not yet in RePEc: Add citation now

  12. Dehez, Pierre, and Alex Jacquemin. 1975. “A Note on Advertising Policy under Uncertainty and Dynamic Conditions.” Journal of Industrial Economics, 24(1): 73–78.

  13. Donohue, Julie M., Ernst R. Berndt, Meredith Rosenthal, Arnold M. Epstein, and Richard G. Frank. 2004. “Effects of Pharmaceutical Promotion on Adherence to the Treatment Guidelines for Depression.
    Paper not yet in RePEc: Add citation now

  14. Iizuka, Toshiaki, and Ginger Zhe Jin. 2005. “The Effect of Prescription Drug Advertising on Doctor Visits.” Journal of Economics and Management Strategy, 14(3): 701–27.

  15. Kravitz, Richard L., Ronald M. Epstein, Mitchell D. Feldman, Carol E. Franz, RahmanAzari, Michael S. Wilkes, Ladson Hinton, and Peter Franks. 2005. “Influence of Patients’ Requests for Direct-toConsumer Advertised Antidepressants: A Randomized Controlled Trial.” Journal of the American Medical Association, 293(16): 1995–2002.
    Paper not yet in RePEc: Add citation now
  16. Lyles, Alan. 2002. “Direct Marketing of Pharmaceuticals to Consumers.” Annual Review of Public Health, 23: 73–91.
    Paper not yet in RePEc: Add citation now
  17. Masson, A., and P. H. Rubin. 1985. “Matching Prescription Drugs and Consumers––The Benefits of Direct Advertising.” New England Journal of Medicine, 313(8): 513–15.
    Paper not yet in RePEc: Add citation now
  18. Mintzes, Barbara, Morris L. Barer, Richard L. Kravitz, Arminée Kazanjian, Ken Bassett, Joel Lexchin, Robert G. Evans, Richard Pan, and Stephen A. Marion. 2002. “Influence of Direct to Consumer Pharmaceutical Advertising and Patients’ Requests on Prescribing Decisions: Two Site Cross Sectional Survey.” British Medical Journal, 324(7332): 278–79.
    Paper not yet in RePEc: Add citation now
  19. Narayanan, Sridhar, Ramarao Desiraju, and Pradeep K. Chintagunta. 2004. “Return on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions. ” Journal of Marketing, 68(4): 90–105.
    Paper not yet in RePEc: Add citation now

  20. Olson, Mary K. 2002. “Pharmaceutical Policy Change and the Safety of New Drugs.” Journal of Law and Economics, 45(2): 615–42.

  21. Rizzo, John A. 1999. “Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs.” Journal of Law and Economics, 42(1): 89–116.

  22. Rudholm, Niklas. 2004. “Approval Times and the Safety of New Pharmaceuticals.” European Journal of Health Economics, 5(4): 345–50.

  23. Scherer, F. M. 2000. “The Pharmaceutical Industry.” In Handbook of Health Economics, Vol. 1B, ed.
    Paper not yet in RePEc: Add citation now
  24. Sellers, L. J., and Andra Brichacek. 2001. “Flexing Their Budgets: Big Pharma Spend Trends.” Pharmaceutical Executive, September 1. http://pharmexec.findpharma.com/pharmexec/article/articleDetail. jsp?id=780&sk=&date=&pageID=3.
    Paper not yet in RePEc: Add citation now
  25. Spence, Michele M., Stephanie S. Teleki, T. Craig Cheetham, Stuart O. Schweitzer, and Mirta Millares. 2005. “Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on Appropriateness of Prescribing.” Medical Care Research and Review, 62(5): 544–59.
    Paper not yet in RePEc: Add citation now
  26. The Kaiser Family Foundation. 2009. “Trends in Promotional Spending for Prescription Drugs, 1996– 2008.” http://facts.kff.org/chart.aspx?ch=225.
    Paper not yet in RePEc: Add citation now
  27. U.S. Food and Drug Administration. 2005. Center for Drug Evaluation and Research 2005 Report to the Nation: Improving Public Health Through Human Drugs. Rockville, MD.
    Paper not yet in RePEc: Add citation now
  28. U.S. General Accounting Office. 2002. Prescription Drugs: FDA Oversight of Direct-to-Consumer Advertising Has Limitations. GAO-03-177. Washington, DC, October.
    Paper not yet in RePEc: Add citation now
  29. Wazana, Ashley. 2000. “Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?” Journal of the American Medical Association, 283(3): 373–80.
    Paper not yet in RePEc: Add citation now
  30. West, Diane. 2007. “Spend Trends 2007: Hang 10, DTC Hits Its first Decade.” Pharmaceutical Executive, May 1. http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=423215&sk =&date=&pageID=3.
    Paper not yet in RePEc: Add citation now
  31. Wooldridge, Jeffrey M. 2002. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press.
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. Quantifying Healthy Days Lost to the Non-Medical Use of Prescription Drugs (NMUPD) among a Sample of College Students. (2022). Divin, Amanda L ; Zullig, Keith J.
    In: Applied Research in Quality of Life.
    RePEc:spr:ariqol:v:17:y:2022:i:2:d:10.1007_s11482-021-09919-5.

    Full description at Econpapers || Download paper

  2. Competing with precision: incentives for developing predictive biomarker tests. (2022). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R.
    In: Discussion Paper Series in Economics.
    RePEc:hhs:nhheco:2022_006.

    Full description at Econpapers || Download paper

  3. Analysis of Risk Factors in the Channels of Drug Distribution: Professional Perspectives. (2020). Fajsi, Angela ; Moraa, Slobodan ; Gruji, Jelena.
    In: Sustainability.
    RePEc:gam:jsusta:v:12:y:2020:i:11:p:4787-:d:370184.

    Full description at Econpapers || Download paper

  4. The Unexpected Consequences of Generic Entry. (2019). Ornaghi, Carmine ; Castanheira, Micael ; Siotis, Georges ; de Moura, Micael Castanheira .
    In: ULB Institutional Repository.
    RePEc:ulb:ulbeco:2013/298643.

    Full description at Econpapers || Download paper

  5. The unexpected consequences of generic entry. (2019). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:68:y:2019:i:c:s0167629618305332.

    Full description at Econpapers || Download paper

  6. The Unexpected Consequences of Generic Entry. (2019). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael.
    In: Working Papers ECARES.
    RePEc:eca:wpaper:2013/293928.

    Full description at Econpapers || Download paper

  7. Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws. (2018). Richards, Michael R ; Nathenson, Robert.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:18:y:2018:i:3:d:10.1007_s10754-018-9234-3.

    Full description at Econpapers || Download paper

  8. Consumer Learning and the Entry of Generic Pharmaceuticals. (2017). Bairoliya, Neha ; Petrin, Amil ; McCullough, Jeffrey S ; Karaca-Mandic, Pinar.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:23662.

    Full description at Econpapers || Download paper

  9. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication. (2015). Bradford, W. David ; Kleit, Andrew N..
    In: Health Economics.
    RePEc:wly:hlthec:v:24:y:2015:i:7:p:859-875.

    Full description at Econpapers || Download paper

  10. The effects of direct-to-consumer advertising of pharmaceuticals on adherence. (2015). , Cardon .
    In: Applied Economics.
    RePEc:taf:applec:v:47:y:2015:i:50:p:5432-5444.

    Full description at Econpapers || Download paper

  11. The Regulation of Direct-to-Consumer Advertising of Pharmaceuticals in a Managed Care Setting. (2015). Ryan, Matthew ; Vaithianathan, Rhema .
    In: Journal of Public Economic Theory.
    RePEc:bla:jpbect:v:17:y:2015:i:6:p:986-1021.

    Full description at Econpapers || Download paper

  12. Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising. (2014). Biegler, Paul .
    In: Journal of Business Ethics.
    RePEc:kap:jbuset:v:123:y:2014:i:1:p:145-155.

    Full description at Econpapers || Download paper

  13. Effects of Pharmaceutical Promotion: A Review and Assessment. (2013). Dave, Dhaval.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:18830.

    Full description at Econpapers || Download paper

  14. The Relationship Between DTCA, Drug Requests, and Prescriptions: Uncovering Variation in Specialty and Space. (2013). Venkataraman, Sriram ; Landsman, Vardit ; Stremersch, Stefan .
    In: Marketing Science.
    RePEc:inm:ormksc:v:32:y:2013:i:1:p:89-110.

    Full description at Econpapers || Download paper

  15. Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?. (2013). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:32:y:2013:i:1:p:268-285.

    Full description at Econpapers || Download paper

  16. Informing the uninformed: How drug advertising affects check-up visits. (2013). Wendling, Brett ; Hosken, Daniel .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:2:p:181-194.

    Full description at Econpapers || Download paper

  17. Direct-to-consumer advertising and consumer welfare. (2013). Jayawardhana, Jayani .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:2:p:164-180.

    Full description at Econpapers || Download paper

  18. Quality competition with motivated providers and sluggish demand. (2013). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto.
    In: Journal of Economic Dynamics and Control.
    RePEc:eee:dyncon:v:37:y:2013:i:10:p:2041-2061.

    Full description at Econpapers || Download paper

  19. Impact of Direct?to?Consumer Advertising on Pharmaceutical Prices and Demand. (2012). Saffer, Henry ; Dave, Dhaval.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:79:y:2012:i:1:p:97-126.

    Full description at Econpapers || Download paper

  20. Misleading advertising in duopoly. (2012). Hattori, Keisuke ; Higashida, Keisaku.
    In: Canadian Journal of Economics/Revue canadienne d'économique.
    RePEc:wly:canjec:v:45:y:2012:i:3:p:1154-1187.

    Full description at Econpapers || Download paper

  21. Role of Socioeconomic Status on Consumers’ Attitudes Towards DTCA of Prescription Medicines in Australia. (2012). Lee, Johnson ; Chaar, Betty .
    In: Journal of Business Ethics.
    RePEc:kap:jbuset:v:105:y:2012:i:4:p:447-460.

    Full description at Econpapers || Download paper

  22. Direct to Consumer Advertising for Pharmaceuticals: Research Amid the Controversy. (2012). Kleit, Andrew N. ; Bradford, David W..
    In: Chapters.
    RePEc:elg:eechap:14021_31.

    Full description at Econpapers || Download paper

  23. Can Credence Advertising Effects Be Isolated? Can They Be Negative?: Evidence from Pharmaceuticals. (2011). Kleit, Andrew N ; Bradford, David W.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:78:y:2011:i:1:p:167-190.

    Full description at Econpapers || Download paper

  24. Side Effects of Competition: the Role of Advertising and Promotion in Pharmaceutical Markets. (2011). Markowitz, Sara ; David, Guy.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:17162.

    Full description at Econpapers || Download paper

  25. Living in the “land of no”? Consumer perceptions of healthy lifestyle portrayals in direct-to-consumer advertisements of prescription drugs. (2011). Tietbohl, Caroline ; May, Suepattra G. ; Pagan, Jose A. ; Frosch, Dominick L..
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:73:y:2011:i:7:p:995-1002.

    Full description at Econpapers || Download paper

  26. Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?. (2010). de Bakker, Frank ; Pol, Pepijn .
    In: Journal of Business Ethics.
    RePEc:kap:jbuset:v:94:y:2010:i:2:p:211-224.

    Full description at Econpapers || Download paper

  27. Detailing vs. Direct-to-Consumer Advertising in the Prescription Pharmaceutical Industry. (2010). Bhardwaj, Pradeep ; Bala, Ram.
    In: Management Science.
    RePEc:inm:ormnsc:v:56:y:2010:i:1:p:148-160.

    Full description at Econpapers || Download paper

  28. Competition and quality in health care markets: A differential-game approach. (2010). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto ; Brekke, Kurt.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:29:y:2010:i:4:p:508-523.

    Full description at Econpapers || Download paper

  29. Marketing and societal welfare: A multiple stakeholder approach. (2010). Matear, Margaret ; Dacin, Peter A..
    In: Journal of Business Research.
    RePEc:eee:jbrese:v:63:y:2010:i:11:p:1173-1178.

    Full description at Econpapers || Download paper

  30. Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?. (2010). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:8076.

    Full description at Econpapers || Download paper

  31. The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation. (2010). Richards-Shubik, Seth ; Markowitz, Sara ; David, Guy.
    In: American Economic Journal: Economic Policy.
    RePEc:aea:aejpol:v:2:y:2010:i:4:p:1-25.

    Full description at Econpapers || Download paper

  32. The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation. (2009). Richards-Shubik, Seth ; Markowitz, Sara ; David, Guy.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:14634.

    Full description at Econpapers || Download paper

  33. Trials, tricks and transparency: How disclosure rules affect clinical knowledge. (2009). Porteiro, Nicolás ; González, Paula ; Dahm, Matthias ; Gonzalez, Paula.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:28:y:2009:i:6:p:1141-1153.

    Full description at Econpapers || Download paper

  34. Marketing and pricing strategies of online pharmacies. (2009). LEVAGGI, ROSELLA ; Zani, Claudia ; Gelatti, Umberto ; Domenighini, Serena ; Schulz, Peter J. ; Bressanelli, Maura ; Caimi, Luigi ; Orizio, Grazia .
    In: Health Policy.
    RePEc:eee:hepoli:v:92:y:2009:i:2-3:p:187-196.

    Full description at Econpapers || Download paper

  35. Competition and quality in regulated markets: a differential-game approach. (2008). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto ; Brekke, Kurt.
    In: Discussion Papers.
    RePEc:yor:yorken:08/05.

    Full description at Econpapers || Download paper

  36. Challenges for Corporate Ethics in Marketing Genetic Tests. (2008). Ozdemir, Vural ; Williams-Jones, Bryn .
    In: Journal of Business Ethics.
    RePEc:kap:jbuset:v:77:y:2008:i:1:p:33-44.

    Full description at Econpapers || Download paper

  37. Competition and Quality in Regulated Markets: a Differential-Game Approach. (2008). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto ; Brekke, Kurt.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:6801.

    Full description at Econpapers || Download paper

  38. Pharmaceutical Patents: Incentives for R&D or Marketing?. (2008). Straume, Odd Rune ; Brekke, Kurt.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_2433.

    Full description at Econpapers || Download paper

  39. Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs. (2008). Linnosmaa, Ismo.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:8:y:2008:i:2:n:8.

    Full description at Econpapers || Download paper

  40. Private Profits and Public Health: Does Advertising of Smoking Cessation Products Encourage Smokers to Quit?. (2007). Mathios, Alan ; Kenkel, Donald ; Avery, Rosemary ; Lillard, Dean R..
    In: Journal of Political Economy.
    RePEc:ucp:jpolec:v:115:y:2007:p:447-481.

    Full description at Econpapers || Download paper

  41. Sustaining Social Security. (2007). Niepelt, Dirk ; Gonzalez-Eiras, Martin.
    In: 2007 Meeting Papers.
    RePEc:red:sed007:95.

    Full description at Econpapers || Download paper

  42. Advertising and generic market entry. (2007). Konigbauer, Ingrid .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:26:y:2007:i:2:p:286-305.

    Full description at Econpapers || Download paper

  43. Private Profits and Public Health: Does Advertising Smoking Cessation Products Encourage Smokers to Quit?. (2006). Mathios, Alan ; Kenkel, Donald ; Avery, Rosemary ; Lillard, Dean R..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:11938.

    Full description at Econpapers || Download paper

  44. Dealing with Rising Health Care Costs: The Case of Pharmaceuticals. (2006). Konigbauer, Ingrid .
    In: Munich Dissertations in Economics.
    RePEc:lmu:dissen:5640.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-02-01 15:49:56 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.